Oncolytic virus with an immune stimulatory payload for osteosarcoma therapy
Cancer Immunology, Immunotherapy · 2026
DOI: 10.1007/s00262-026-04458-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2026. Verfasst von Sumbul Khan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Scott Ritchey Research Center, College of Veterinary Medicine, Auburn University, Auburn, AL, USA. Hauptthemen laut MEDLINE: Osteosarcoma, Oncolytic Virotherapy, Oncolytic Viruses, Bone Neoplasms. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH NCI.
Abstract (Originalsprache)
Osteosarcoma (OS) is a highly aggressive bone malignancy that predominantly affects children and young adults. There have been no major changes in patient survival in the past four decades. Therefore, new therapeutic interventions are needed. We have developed an enhanced conditionally replicative canine oncolytic adenovirus, CAV2-AU-M3, armed with an anti-PD1 heavy-chain antibody (HcAb), and evaluated its efficacy against osteosarcoma across four canine cell lines. CAV2-AU-M3 was characterized for its infectivity, lytic properties, and anti-PD1 Ab production in monolayer and spheroid cultures. Additionally, the impact of intratumoral administration of the virus on tumor growth was measured in a mouse model. Our study demonstrates that CAV2-AU-M3 infects and lyses different canine OS cell lines at varying rates but produces anti-PD1 Ab at similar levels across all osteosarcoma cell lines. Additionally, anti-PD1 Ab produced by CAV2-AU-M3 can effectively bind the cell surface PD1 receptor and inhibit the binding of PDL1 to PD1 receptors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Scott Ritchey Research Center, College of Veterinary Medicine, Auburn University, Auburn, AL, USA.
- Department of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, AL, USA.
- Department of Mathematics and Statistics, College of Sciences and Mathematics, Auburn University, Auburn, AL, USA.
- Department of Industrial and Systems Engineering, Samuel Ginn College of Engineering, Auburn University, Auburn, AL, USA.
- Scott Ritchey Research Center, College of Veterinary Medicine, Auburn University, Auburn, AL, USA. agarwpa@auburn.edu.
- Department of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, AL, USA. agarwpa@auburn.edu.
Förderung
- NCI NIH HHS
- NIH NCI
Zitieren
APA
Khan, S., Higgins, T. A., Shimko-Lofano, I., Sandey, M., Logsdon, E., Bunch, G., Fatemi, Y., Hoffman, L. M. K., Smith, B. F., & Agarwal, P. (2026). Oncolytic virus with an immune stimulatory payload for osteosarcoma therapy. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-026-04458-0
Vancouver
Khan S, Higgins TA, Shimko-Lofano I, Sandey M, Logsdon E, Bunch G, et al. Oncolytic virus with an immune stimulatory payload for osteosarcoma therapy. Cancer Immunology, Immunotherapy. 2026. doi:10.1007/s00262-026-04458-0
BibTeX
@article{Khan2026,
author = {Khan, Sumbul and Higgins, Theresa A and Shimko-Lofano, Isabella and Sandey, Maninder and Logsdon, Emma and Bunch, Gracie and Fatemi, Yasin and Hoffman, Leah M K and Smith, Bruce F and Agarwal, Payal},
title = {Oncolytic virus with an immune stimulatory payload for osteosarcoma therapy},
journal = {Cancer Immunology, Immunotherapy},
year = {2026},
doi = {10.1007/s00262-026-04458-0}
}
EUVIMED